Financials
- Market Capitalization 19.04 M
- Employee 14
- Founded 1997
- CEO N/A
- Website www.lipocine.com
- Headquarter Delaware, United States
- FIGI BBG0029L1X69
- Industry Biotechnology
Related tickers
| # | Name | Price | 24h % | 7d % | 1M % | 1Y % | Market Cap | Last 7 Days | |
|---|---|---|---|---|---|---|---|---|---|
| 4628 | ICU SeaStar Medical Holding Corporation - Common Stock | 4.80 USD | +0.21% | -3.23% | +54.84% | +95.12% | 19.19 M USD | ||
| 4630 | NCEL NewcelX Ltd. - Ordinary Shares | 3.98 USD | -0.50% | +0.51% | +24.37% | -21.65% | 19.09 M USD | ||
| 4649 | ALLR Allarity Therapeutics, Inc. - Common stock | 1.16 USD | +2.65% | +2.65% | -20.00% | +16.00% | 18.46 M USD | ||
| 4652 | PLUR Pluri Inc. - Common Stock | 1.68 USD | +3.07% | -16.42% | -26.96% | -56.04% | 18.13 M USD |
Frequently asked questions about Lipocine Inc. - Common Stock
What is the Lipocine Inc. - Common Stock stock price today?
The current price of Lipocine Inc. - Common Stock (LPCN) is 2.31. Over the past 24 hours, the stock has changed by -1.70%. Follow the LPCN chart for real-time price dynamics.
What is the stock ticker of Lipocine Inc. - Common Stock?
Lipocine Inc. - Common Stock trades under the ticker LPCN. Tickers can differ by exchange, so always check the exchange and instrument details before trading.
Is Lipocine Inc. - Common Stock stock going up?
LPCN has changed by -3.35% over the last week, +0.87% over the last month, and -20.34% over the last year. Review the chart to see whether the current move is part of a broader trend.
What was Lipocine Inc. - Common Stock net income for the last quarter?
Lipocine Inc. - Common Stock reported net income of -3.67 M for the last quarter. The previous quarter showed -2.37 M, which means net income changed by -54.93%.
How many employees does Lipocine Inc. - Common Stock have?
As of the latest available data, Lipocine Inc. - Common Stock has 14 employees. Workforce size can provide additional context about the company's scale and operations.
What is Lipocine Inc. - Common Stock EBITDA?
Lipocine Inc. - Common Stock EBITDA is -3.95 M, and its EBITDA margin is -3 304.84%. EBITDA is commonly used to evaluate operating performance before interest, taxes, depreciation, and amortization.
How can I buy Lipocine Inc. - Common Stock stock?
You can buy Lipocine Inc. - Common Stock (LPCN) through a broker that provides access to the relevant stock exchange. Before trading, check commissions, execution conditions, account type, and whether the stock fits your investment plan.
Should I invest in Lipocine Inc. - Common Stock stock?
Investing in Lipocine Inc. - Common Stock requires reviewing its financial statements, valuation, earnings outlook, news, technical picture, and market risks. Use the LPCN chart and related analysis on metatrader.com as part of your research.